|Day Low/High||7.02 / 7.07|
|52 Wk Low/High||3.35 / 7.86|
A handful of stocks trading near $10 were poised to move on above-average volume during Monday's regular session.
A handful of stocks trading below $10 were poised to move on above-average volume during Thursday's trading session.
News about FDA drug approvals and rejections can send biotech stocks rocketing or plummeting. Here are ten companies facing FDA approval decisions this year.
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its fourth quarter financial results on February 22, 2010 at approximately 4:30 p.
XenoPort, Inc. (Nasdaq:XNPT) announced today that the U.
XenoPort, Inc. (Nasdaq: XNPT) announced today that, subject to the approval of the U.
February's list of important, potentially stock-moving biotech events.
GlaxoSmithKline, XenoPort drug candidate gets extended FDA regulatory review
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
An expected deal for its diabetes drug may not happen until next year.
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.
Depomed says its post-shingles pain drug succeeded it trial, and shares hit three-year high
XenoPort shares fall as diabetic pain drug fails to meet goal in midstage clinical trial
XenoPort, GlaxoSmithKline pain drug fails to meet treatment goal in midstage clinical trial
XenoPort and Glaxo say FDA accepts new application for Solzira; XenoPort will be paid $23M
King Pharmaceuticals drags health stocks lower after missing on second quarter earnings.
Presidential Life, Home Bancshares, Owens Corning, Transdigm and Xenoport upgraded.
Foundation Coal, United Stationers, Diana Shipping upgraded; Arbitron, Xenoport downgraded.
Arena gets an upgrade by a analyst with a positive safety outlook.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.